Insider Transactions in Q4 2024 at Hims & Hers Health, Inc. (HIMS)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 19
2024
|
Michael Chi Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
7,500
-3.92%
|
$165,000
$22.0 P/Share
|
|
Nov 19
2024
|
Michael Chi Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+3.77%
|
$97,500
$13.9 P/Share
|
|
Nov 18
2024
|
Irene Becklund PAO |
SELL
Open market or private sale
|
Direct |
472
-8.45%
|
$8,968
$19.42 P/Share
|
|
Nov 18
2024
|
Irene Becklund PAO |
BUY
Exercise of conversion of derivative security
|
Direct |
472
+7.79%
|
$4,248
$9.41 P/Share
|
|
Nov 18
2024
|
Melissa Baird Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
58,750
-2.2%
|
$1,175,000
$20.92 P/Share
|
|
Nov 18
2024
|
Melissa Baird Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
58,750
+7.86%
|
$0
$0.4 P/Share
|
|
Nov 14
2024
|
Anja Manuel Director |
BUY
Open market or private purchase
|
Direct |
1,000
+16.67%
|
$24,000
$24.5 P/Share
|
|
Nov 13
2024
|
David B Wells Director |
SELL
Open market or private sale
|
Direct |
40,000
-20.4%
|
$1,160,000
$29.99 P/Share
|
|
Nov 13
2024
|
Oluyemi Okupe Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
142,886
-14.63%
|
$4,000,808
$28.98 P/Share
|
|
Nov 13
2024
|
Oluyemi Okupe Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
109,309
+18.89%
|
$874,472
$8.27 P/Share
|
|
Nov 12
2024
|
Anja Manuel Director |
BUY
Open market or private purchase
|
Direct |
4,000
+50.0%
|
$104,000
$26.94 P/Share
|
|
Nov 12
2024
|
Soleil Boughton Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,338
-1.38%
|
$60,788
$26.46 P/Share
|
|
Nov 11
2024
|
Michael Chi Chief Commercial Officer |
SELL
Bona fide gift
|
Direct |
10,000
-5.16%
|
-
|
|
Nov 11
2024
|
Michael Chi Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
7,259
-3.61%
|
$174,216
$24.77 P/Share
|
|
Nov 11
2024
|
Michael Chi Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,259
+3.48%
|
$43,554
$6.82 P/Share
|
|
Nov 11
2024
|
Patrick Harrison Carroll Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,707
-2.39%
|
$131,796
$28.24 P/Share
|
|
Nov 06
2024
|
Patrick Harrison Carroll Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
15,000
-7.08%
|
$330,000
$22.07 P/Share
|
|
Nov 05
2024
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
188,888
-34.74%
|
$3,966,648
$21.0 P/Share
|
|
Nov 05
2024
|
Andrew Dudum Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
188,888
+42.47%
|
$377,776
$2.43 P/Share
|
|
Nov 05
2024
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
144,444
-7.93%
|
$3,033,324
$21.01 P/Share
|
|
Nov 05
2024
|
Michael Chi Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
2,054
-1.05%
|
$45,188
$22.0 P/Share
|
|
Nov 05
2024
|
Michael Chi Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,054
+1.04%
|
$22,594
$11.53 P/Share
|
|
Oct 29
2024
|
Soleil Boughton Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,339
-1.36%
|
$53,797
$23.16 P/Share
|
|
Oct 25
2024
|
Michael Chi Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
17,304
-8.19%
|
$380,688
$22.0 P/Share
|
|
Oct 25
2024
|
Michael Chi Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,304
+7.57%
|
$86,520
$5.01 P/Share
|
|
Oct 21
2024
|
Michael Chi Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
7,500
-3.72%
|
$165,000
$22.2 P/Share
|
|
Oct 21
2024
|
Michael Chi Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+3.59%
|
$97,500
$13.9 P/Share
|
|
Oct 16
2024
|
Irene Becklund PAO |
SELL
Open market or private sale
|
Direct |
471
-8.43%
|
$10,362
$22.64 P/Share
|
|
Oct 16
2024
|
Irene Becklund PAO |
BUY
Exercise of conversion of derivative security
|
Direct |
471
+7.77%
|
$4,239
$9.41 P/Share
|
|
Oct 15
2024
|
Michael Chi Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
75,493
-28.02%
|
$1,660,846
$22.0 P/Share
|
|
Oct 15
2024
|
Michael Chi Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
75,493
+7.06%
|
$679,437
$9.32 P/Share
|
|
Oct 15
2024
|
Soleil Boughton Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,339
-1.34%
|
$46,780
$20.41 P/Share
|
|
Oct 14
2024
|
Oluyemi Okupe Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
269,739
-11.56%
|
$5,394,780
$20.19 P/Share
|
|
Oct 14
2024
|
Oluyemi Okupe Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
219,514
+19.34%
|
$1,756,112
$8.27 P/Share
|
|
Oct 07
2024
|
Oluyemi Okupe Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
9,868
-4.79%
|
$187,492
$19.96 P/Share
|
|
Oct 07
2024
|
Melissa Baird Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
58,750
-4.35%
|
$1,116,250
$19.57 P/Share
|
|
Oct 07
2024
|
Melissa Baird Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
58,750
+7.86%
|
$0
$0.4 P/Share
|
|
Oct 02
2024
|
Oluyemi Okupe Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
11,581
-1.79%
|
$220,039
$19.0 P/Share
|
|
Oct 02
2024
|
Oluyemi Okupe Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,437
+2.88%
|
$32,185
$5.01 P/Share
|
|
Oct 01
2024
|
Soleil Boughton Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,339
-1.32%
|
$42,102
$18.5 P/Share
|
|
Oct 01
2024
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
144,444
-18.16%
|
$2,599,992
$18.22 P/Share
|
|
Oct 01
2024
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
188,888
-47.7%
|
$3,399,984
$18.18 P/Share
|
|
Oct 01
2024
|
Andrew Dudum Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
188,888
+42.47%
|
$377,776
$2.43 P/Share
|